Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

138.41
Delayed Data
As of Jan 20
 -0.31 / -0.22%
Today’s Change
125.08
Today|||52-Week Range
212.00
-18.38%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close138.62
Today’s open146.16
Day’s range137.90 - 146.44
Volume576,251
Average volume (3 months)717,985
Market cap$17.7B
Data as of 4:00pm ET, 01/20/2022

Growth & Valuation

Earnings growth (last year)+7.96%
Earnings growth (this year)+13.19%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+124.28%
P/E ratioNM
Price/Sales30.32
Price/Book16.99

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-0.02-0.03%
CTLTCatalent Inc+0.05+0.05%
VTRSViatris Inc-0.08-0.54%
HZNPHorizon Therapeutics...-1.47-1.67%
Data as of 4:00pm ET, 01/20/2022

Financials

Next reporting dateFebruary 10, 2022
EPS forecast (this quarter)-$1.56
Annual revenue (last year)$492.9M
Annual profit (last year)-$858.3M
Net profit margin-174.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts